Grants and Contributions:

Title:
819504
Agreement Number:
819504
Agreement Value:
$15,000,000.00
Agreement Date:
Aug 10, 2023 - Jan 1, 2050
Description:
This project is to build a Good Manufacturing Practices (GMP) facility to manufacture lipids, conduct lipid nanoparticle (LNP) formulation and expand the company's existing vaccine manufacturing capacity in Calgary, AB.
Organization:
Innovation, Science and Economic Development Canada
Expected Results:

This investment will create national ecosystems and secure economic, innovation and public benefits, while strengthening Canada's epidemic and pandemic preparedness by growing a strong, competitive domestic life sciences sector.

Location:
Calgary, Alberta, CA T2A7H8
Reference Number:
033-2023-2024-Q2-819504
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
717183537
Recipient Type:
For-profit organization
Additional Information:

Please note this update includes a change to improve standardization of reporting across projects. The end date was updated from the end of the work phase of the project (31/12/2025) to the current end date of the contract (12/31/2040). This is not an extension. The end date now reflects the entirety of the agreement duration, including the benefit phase and residual audit period. The original start date was updated to reflect the correct execution date.

Amendment Date
Mar 31, 2026
Recipient's Operating Name:
Northern RNA Inc.
Recipient's Legal Name:
Northern RNA Inc.
Federal Riding Name:
Calgary Forest Lawn
Federal Riding Number:
48006
Program:
SIF Stream 2 - Growth
Program Purpose:

Encourage R&D that will accelerate technology transfer and commercialization of innovative products, processes and services; Facilitate the growth and expansion of firms in Canada; Attract and retain large scale investments to Canada; and-Advance industrial research, development and technology demonstration through collaboration between academia, non-profit organizations and the private sector.

NAICS Code:
339900
Amendments: